TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Adherium Ltd. ( (AU:ADR) ) has shared an announcement.
Adherium Ltd. has announced the quotation of 71,005,701 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective November 14, 2025. This move is part of the company’s strategy to enhance its capital structure, potentially strengthening its market position in the digital health sector and providing additional resources to support its growth and innovation initiatives.
More about Adherium Ltd.
Adherium Ltd. operates in the healthcare industry, focusing on developing and providing digital health technologies, particularly for respiratory conditions. The company is known for its innovative solutions that integrate with inhalers to monitor medication adherence, aiming to improve patient outcomes and reduce healthcare costs.
Technical Sentiment Signal: Sell
Current Market Cap: A$9.69M
Learn more about ADR stock on TipRanks’ Stock Analysis page.